{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:58:37Z","timestamp":1791237517928,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.msard.2023.104921","type":"journal-article","created":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T15:45:42Z","timestamp":1690645542000},"page":"104921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Higher MRI lesion load in multiple sclerosis is related to the N-glycosylation changes of cerebrospinal fluid immunoglobulin G"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8138-4170","authenticated-orcid":false,"given":"Ana","family":"Tur\u010di\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Radovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017deljka","family":"Vogrinc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Habek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunja","family":"Rogi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Gabeli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljiljana","family":"Zaninovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordan","family":"Lauc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0624-7170","authenticated-orcid":false,"given":"Ivan","family":"Gudelj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2023.104921_bib0036","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1080\/19420862.2019.1608143","article-title":"Effects of terminal galactose residues in mannose \u03b11-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies","volume":"11","author":"Aoyama","year":"2019","journal-title":"MAbs"},{"key":"10.1016\/j.msard.2023.104921_bib0020","doi-asserted-by":"crossref","unstructured":"Behdenna A., Haziza J., Azencott C.A., et\u00a0al. pyComBat, a Python tool for batch effects correction in high-throughput molecular data using empirical Bayes methods. Available from: https:\/\/www.gnu.org\/licenses\/gpl-3.0.en.html (accessed 6 March 2023).","DOI":"10.1186\/s12859-023-05578-5"},{"key":"10.1016\/j.msard.2023.104921_bib0006","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00401-015-1500-6","article-title":"Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants","volume":"130","author":"Blauth","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.msard.2023.104921_bib0002","doi-asserted-by":"crossref","first-page":"7864","DOI":"10.1073\/pnas.1522730113","article-title":"Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins","volume":"113","author":"Br\u00e4ndle","year":"2016","journal-title":"P. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.msard.2023.104921_bib0024","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/jamaneurol.2021.1116","article-title":"Association of a marker of N-Acetylglucosamine with progressive multiple sclerosis and neurodegeneration","volume":"78","author":"Brandt","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2023.104921_bib0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ana.21311","article-title":"Homogeneity of active demyelinating lesions in established multiple sclerosis","volume":"63","author":"Breij","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2023.104921_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.724379","article-title":"Cytokines in the Immune Microenvironment Change the Glycosylation of IgG by Regulating Intracellular Glycosyltransferases","volume":"12","author":"Cao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2023.104921_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines8100410","article-title":"Glycosylation alterations in multiple sclerosis show increased proinflammatory potential","volume":"8","author":"Cvetko","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.msard.2023.104921_bib0027","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1177\/1352458516631036","article-title":"Abnormal galactosylation of immunoglobulin G in cerebrospinal fluid of multiple sclerosis patients","volume":"22","author":"Decker","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104921_bib0011","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3389\/fimmu.2017.00877","article-title":"Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor- and complement-mediated-effector activities","volume":"8","author":"Dekkers","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2023.104921_bib0013","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/art.27533","article-title":"Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis","volume":"62","author":"Ercan","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.msard.2023.104921_bib0015","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1021\/pr401213z","article-title":"IgG Fc N-glycosylation in Guillain-Barr\u00e9 syndrome treated with immunoglobulins","volume":"13","author":"Fokkink","year":"2014","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.msard.2023.104921_bib0032","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/brain\/awu405","article-title":"Genetic variants are major determinants of CSF antibody levels in multiple sclerosis","volume":"138","author":"Goris","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.msard.2023.104921_bib0009","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00281-012-0307-y","article-title":"Pathogenesis of multiple sclerosis via environmental and genetic dysregulation of N-glycosylation","volume":"34","author":"Grigorian","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.msard.2023.104921_bib0012","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cellimm.2018.07.009","article-title":"Immunoglobulin G glycosylation in aging and diseases","volume":"333","author":"Gudelj","year":"2018","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.msard.2023.104921_bib0033","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3325\/cmj.2022.63.379","article-title":"Treatment of relapsing multiple sclerosis - recommendations of the Croatian neurological society","volume":"63","author":"Habek","year":"2022","journal-title":"Croat. Med. J."},{"key":"10.1016\/j.msard.2023.104921_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.972168","article-title":"Specific location of galactosylation in an afucosylated antiviral monoclonal antibody affects its Fc\u03b3RIIIA binding affinity","volume":"13","author":"Hatfield","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2023.104921_bib0017","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","article-title":"Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report","volume":"57","author":"Hospital","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2023.104921_bib0025","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/glycob\/cwab053","article-title":"Analysis of site-specific glycan profiles of serum proteins in patients with multiple sclerosis or neuromyelitis optica spectrum disorder - A pilot study","volume":"31","author":"Ip","year":"2021","journal-title":"Glycobiology"},{"key":"10.1016\/j.msard.2023.104921_bib0008","doi-asserted-by":"crossref","first-page":"14987","DOI":"10.1038\/s41598-021-94423-x","article-title":"Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study","volume":"11","author":"Karrenbauer","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2023.104921_bib0014","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ebiom.2017.01.033","article-title":"Galactosylation and sialylation levels of IgG predict relapse in patients with PR3-ANCA associated vasculitis","volume":"17","author":"Kemna","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.msard.2023.104921_bib0030","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11481-021-09996-1","article-title":"Aberrant immunoglobulin G glycosylation in multiple sclerosis","volume":"17","author":"Kennedy","year":"2022","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.msard.2023.104921_bib0021","series-title":"Positioning and Power in Academic Publishing: Players, Agents and Agendas - Proceedings of the 20th International Conference on Electronic Publishing, ELPUB. 2016","first-page":"87","article-title":"Jupyter Notebooks\u2014A publishing format for reproducible computational workflows","author":"Kluyver","year":"2016"},{"key":"10.1016\/j.msard.2023.104921_bib0028","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/CIRCRESAHA.117.312174","article-title":"Glycosylation profile of immunoglobulin G is cross-sectionally associated with cardiovascular disease risk score and subclinical atherosclerosis in two independent cohorts","volume":"122","author":"Menni","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.msard.2023.104921_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.818382","article-title":"Enhanced immunomodulatory effect of intravenous immunoglobulin by Fc galactosylation and nonfucosylation","volume":"13","author":"Mimura","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2023.104921_bib0010","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cell.2006.08.019","article-title":"Glycosylation in cellular mechanisms of health and disease","volume":"126","author":"Ohtsubo","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.msard.2023.104921_bib0019","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12967-018-1695-0","article-title":"N-glycosylation patterns of plasma proteins and immunoglobulin G in chronic obstructive pulmonary disease","volume":"16","author":"Pavi\u0107","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.msard.2023.104921_bib0018","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.010090","article-title":"High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations","volume":"10","author":"Pu\u010di\u0107","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.msard.2023.104921_bib0016","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-510X(94)90298-4","article-title":"Flow rate of cerebrospinal fluid (CSF) \u2014 A concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases","volume":"122","author":"Reiber","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2023.104921_bib0023","doi-asserted-by":"crossref","first-page":"15222","DOI":"10.18632\/aging.103884","article-title":"Global variability of the human IgG glycome","volume":"12","author":"\u0160tambuk","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.msard.2023.104921_bib0004","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3390\/diagnostics12030720","article-title":"Decreased intrathecal concentrations of free light chains kappa in multiple sclerosis patients taking very high effective disease-modifying treatment","volume":"12","author":"S\u00fc\u00dfe","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.msard.2023.104921_bib0003","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2023.104921_bib0007","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/brain\/awv105","article-title":"Defining high, medium and low impact prognostic factors for developing multiple sclerosis","volume":"138","author":"Tintore","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.msard.2023.104921_bib0001","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3389\/fimmu.2020.00760","article-title":"B and T cells driving multiple sclerosis: identity, mechanisms and potential triggers","volume":"11","author":"van Langelaar","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2023.104921_bib0026","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12974-015-0450-1","article-title":"Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid","volume":"12","author":"Wuhrer","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.msard.2023.104921_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.861885","article-title":"Multiple sclerosis and the risk of cardiovascular diseases: a Mendelian randomization study","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823004224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823004224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T16:02:36Z","timestamp":1727452956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823004224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":36,"alternative-id":["S2211034823004224"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.104921","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher MRI lesion load in multiple sclerosis is related to the N-glycosylation changes of cerebrospinal fluid immunoglobulin G","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.104921","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104921"}}